PROMIS NEUROSCIENCES (F:23J0) — Stock Price
PROMIS NEUROSCIENCES (F:23J0) is currently trading at €6.90 EUR, up 2.99% today. Over the past 52 weeks, shares have ranged between €0.27 and €6.90. This page tracks PROMIS NEUROSCIENCES's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of PROMIS NEUROSCIENCES.
PROMIS NEUROSCIENCES (23J0) Stock Price Chart — Daily History & Trading Volume
The chart below tracks PROMIS NEUROSCIENCES's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
PROMIS NEUROSCIENCES Income Statement — Revenue, Profit & Earnings by Year
PROMIS NEUROSCIENCES's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year |
|---|
| Total Revenue |
| Cost of Revenue |
| Gross Profit |
| Research & Development |
| SG&A |
| Total Operating Expenses |
| Operating Income |
| EBITDA |
| EBIT |
| Interest Expense |
| Income Before Tax |
| Income Tax Expense |
| Net Income |
PROMIS NEUROSCIENCES Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes PROMIS NEUROSCIENCES's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year |
|---|
| Total Assets |
| Total Current Assets |
| Cash & Equivalents |
| Short-term Investments |
| Net Receivables |
| Inventory |
| Property, Plant & Equipment |
| Goodwill |
| Total Liabilities |
| Total Current Liabilities |
| Long-term Debt |
| Net Debt |
| Total Stockholder Equity |
| Retained Earnings |
PROMIS NEUROSCIENCES Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how PROMIS NEUROSCIENCES generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year |
|---|
| Operating Cash Flow |
| Capital Expenditures |
| Free Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Dividends Paid |
| Stock-Based Compensation |
| Depreciation |
| Change in Cash |
PROMIS NEUROSCIENCES Earnings History — EPS Actual vs. Analyst Estimates
Track PROMIS NEUROSCIENCES's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Mar 30, 2026 | — | — | — |
| Nov 12, 2025 | -0.24 | 0.00 | — |
| Aug 07, 2025 | -0.29 | -0.22 | -31.82% |
| May 12, 2025 | -0.21 | 0.00 | — |
| Mar 31, 2025 | -0.01 | 0.00 | — |
| Nov 12, 2024 | — | — | — |